Patent · US Active

Modified polynucleotides for treating galactosylceramidase protein deficiency

US9089604B2 · kind B2 · utility

108Cited by

381References

16Claims

0Family size

Assignee

Moderna Therapeutics, Inc. · US

Inventors

Tirtha Chakraborty · Medford, US
Antonin de Fougerolles · Waterloo, BE
Ron Weiss · Newton, US

Key dates

Filing date	Feb 3, 2014
Grant date	Jul 28, 2015
Priority date	—
Expiry date	Feb 3, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.